Association of genetically proxied cancer-targeted drugs with cardiovascular diseases through Mendelian randomization analysis
Abstract Background Cancer-targeted therapies are progressively pivotal in oncological care. Observational studies underscore the emergence of cancer therapy-related cardiovascular toxicity (CTR-CVT), impacting patient outcomes. We aimed to investigate the causal relationship between different types...
Saved in:
Main Authors: | Chuchun Fang, Xuewei Liu, Chen Yu, Songlin Li, Xueying Liu, Shifeng Qiu, Hongbin Liang, Caiwen Ou, Jiancheng Xiu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12967-024-06027-4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Insights Into Causal Effects of Genetically Proxied Lipids and Lipid‐Modifying Drug Targets on Cardiometabolic Diseases
by: Liwan Fu, et al.
Published: (2025-02-01) -
Genetic association of lipid-lowering drug target genes with pancreatic cancer: a Mendelian randomization study
by: Bohan Su, et al.
Published: (2025-01-01) -
Associations between lipid-lowering drugs and urate and gout outcomes: a Mendelian randomization study
by: Min Liu, et al.
Published: (2025-01-01) -
Investigating the role of cathepsins in breast cancer progression: a Mendelian randomization study
by: Shengyi Zhou, et al.
Published: (2025-01-01) -
Single-cell transcriptome-wide Mendelian randomization and colocalization reveals immune-mediated regulatory mechanisms and drug targets for COVID-19Research in context
by: Hui Ying, et al.
Published: (2025-03-01)